Mutation of the 9q34 gene TSC1 in sporadic bladder cancer

N Hornigold, J Devlin, AM Davies, JS Aveyard… - Oncogene, 1999 - nature.com
N Hornigold, J Devlin, AM Davies, JS Aveyard, T Habuchi, MA Knowles
Oncogene, 1999nature.com
Deletions involving chromosome 9 occur in more than 50% of human bladder cancers of all
grades and stages. Most involve loss of the whole chromosome or of an entire chromosome
arm but some small deletions are found which can be used to define critical regions which
may contain tumour suppressor genes. We have localized such a critical region of deletion
at 9q34 between the markers D9S149 and D9S66, an interval which contains the Tuberous
Sclerosis gene TSC1. Single strand conformation polymorphism (SSCP) and sequence …
Abstract
Deletions involving chromosome 9 occur in more than 50% of human bladder cancers of all grades and stages. Most involve loss of the whole chromosome or of an entire chromosome arm but some small deletions are found which can be used to define critical regions which may contain tumour suppressor genes. We have localized such a critical region of deletion at 9q34 between the markers D9S149 and D9S66, an interval which contains the Tuberous Sclerosis gene TSC1. Single strand conformation polymorphism (SSCP) and sequence analysis of TSC1 in bladder tumours and cell lines with 9q34 loss of heterozygosity (LOH) has identified five mutations in retained TSC1 alleles. Our results support the hypothesis that TSC1 can act as a bladder tumour suppressor gene.
nature.com